Jang Younghoon, Wang Chaochen, Zhuang Lenan, Liu Chengyu, Ge Kai
Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, USA.
Transgenic Core, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA.
J Mol Biol. 2017 Jun 30;429(13):2046-2054. doi: 10.1016/j.jmb.2016.12.016. Epub 2016 Dec 21.
Transcriptional enhancers play a key role in cell type-specific gene expression and cell fate transition. Enhancers are marked by histone H3K4 mono- and di-methylation (H3K4me1/2). The tumor suppressor MLL4 (KMT2D) is a major enhancer H3K4 mono- and di-methyltransferase with a partial functional redundancy with MLL3 (KMT2C). However, the functional role of MLL4 enzymatic activity remains elusive. To address this issue, we have generated MLL4 enzyme-dead knock-in (KI) embryonic stem (ES) cells and mice, which carry Y5477A/Y5523A/Y5563A mutations in the enzymatic SET domain of the MLL4 protein. Homozygous MLL4 enzyme-dead KI (Mll4) mice are embryonic lethal and die around E10.5, which phenocopies Mll4 knockout mice. Interestingly, enzyme-dead MLL4 protein in ES cells is highly unstable. Like Mll4 knockout ES cells, Mll4 ES cells show reduced levels of H3K4me1/2. Furthermore, we show that ectopic expression of histone H3.3 lysine 4-to-methionine (K4M) mutant, which reduces endogenous H3K4 methylation levels in ES cells, decreases the protein stability of MLL3 and MLL4 but not that of H3K4 methyltransferases SET1A (KMT2F) and SET1B (KMT2G). Taken together, our findings indicate that MLL4 protein stability is tightly regulated by its H3K4 methyltransferase activity.
转录增强子在细胞类型特异性基因表达和细胞命运转变中起关键作用。增强子以组蛋白H3K4单甲基化和二甲基化(H3K4me1/2)为标志。肿瘤抑制因子MLL4(KMT2D)是一种主要的增强子H3K4单甲基化和二甲基转移酶,与MLL3(KMT2C)具有部分功能冗余。然而,MLL4酶活性的功能作用仍不清楚。为了解决这个问题,我们构建了MLL4酶失活的敲入(KI)胚胎干细胞和小鼠,它们在MLL4蛋白的酶促SET结构域中携带Y5477A/Y5523A/Y5563A突变。纯合的MLL4酶失活KI(Mll4)小鼠胚胎致死,在大约E10.5时死亡,这与Mll4基因敲除小鼠的表型相似。有趣的是,胚胎干细胞中酶失活的MLL4蛋白高度不稳定。与Mll4基因敲除的胚胎干细胞一样,Mll4胚胎干细胞显示H3K4me1/2水平降低。此外,我们发现组蛋白H3.3赖氨酸4突变为甲硫氨酸(K4M)的突变体异位表达会降低胚胎干细胞中的内源性H3K4甲基化水平,降低MLL3和MLL4的蛋白质稳定性,但不会降低H3K4甲基转移酶SET1A(KMT2F)和SET1B(KMT2G)的蛋白质稳定性。综上所述,我们的研究结果表明,MLL4蛋白稳定性受其H3K4甲基转移酶活性的严格调控。